85 related articles for article (PubMed ID: 27431415)
1. Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.
Dhir M; Jones HL; Shuai Y; Clifford AK; Perkins S; Steve J; Hogg ME; Choudry MH; Pingpank JF; Holtzman MP; Zeh HJ; Bahary N; Bartlett DL; Zureikat AH
Ann Surg Oncol; 2017 Jan; 24(1):150-158. PubMed ID: 27431415
[TBL] [Abstract][Full Text] [Related]
2. Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study.
Guadagni S; Clementi M; Mackay AR; Ricevuto E; Fiorentini G; Sarti D; Palumbo P; Apostolou P; Papasotiriou I; Masedu F; Valenti M; Giordano AV; Bruera G
J Cancer Res Clin Oncol; 2020 May; 146(5):1273-1290. PubMed ID: 32088781
[TBL] [Abstract][Full Text] [Related]
3. Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy.
Datta J; Narayan RR; Goldman DA; Chatila WK; Gonen M; Strong J; Balachandran VP; Drebin JA; Kingham TP; Jarnagin WR; Schultz N; Kemeny NE; D'Angelica MI
Ann Surg; 2022 Nov; 276(5):e474-e482. PubMed ID: 33214457
[TBL] [Abstract][Full Text] [Related]
4. Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases.
Verheij FS; Kuhlmann KFD; Silliman DR; Soares KC; Kingham TP; Balachandran VP; Drebin JA; Wei AC; Jarnagin WR; Cercek A; Kok NFM; Kemeny NE; D'Angelica MI
Ann Surg Oncol; 2023 Dec; 30(13):7950-7959. PubMed ID: 37639032
[TBL] [Abstract][Full Text] [Related]
5. Combined Primary Resection with Hepatic Artery Infusion Pump Implantation Is Safe for Unresectable Colorectal Liver Metastases.
Turley MC; Moore C; Creasy JM; Sharib J; Lan B; Thacker JKM; Migaly J; Zani S; Allen PJ; Mantyh CR; Lidsky ME
J Gastrointest Surg; 2022 Apr; 26(4):764-771. PubMed ID: 34820727
[TBL] [Abstract][Full Text] [Related]
6. Comparison between fluoropyrimidine-hepatic arterial infusion and systemic chemotherapy for unresectable liver metastases: A protocol for systematic review and meta-analysis based on 16 observational studies.
Zhao J; Zheng Y; Liu T; Chang J; Shan H; Cong K
Medicine (Baltimore); 2021 Oct; 100(41):e27483. PubMed ID: 34731127
[TBL] [Abstract][Full Text] [Related]
7. ASO Visual Abstract: Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
Sugumar K; Stitzel H; Wu V; Bajor D; Chakrabarti S; Conces M; Henke L; Lumish M; Mahipal A; Mohamed A; Winter JM; Hardacre JM; Ammori JB; Selfridge JE; Ocuin LM
Ann Surg Oncol; 2024 Jul; 31(7):4466-4467. PubMed ID: 38689171
[No Abstract] [Full Text] [Related]
8. Safety and feasibility of establishing an adjuvant hepatic artery infusion program.
Janczewski LM; Joung RH; Borhani AA; Lewandowski RJ; Velichko YS; Mulcahy MF; Mahalingam D; Law J; Bowman C; Keswani RN; Poylin VY; Bentrem DJ; Merkow RP
HPB (Oxford); 2024 May; 26(5):656-663. PubMed ID: 38383208
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Artery Infusion Chemotherapy for Primary and Secondary Malignancies of the Liver: State of the Art and Current High-Level Evidence.
Kuemmerli C; Hess V; Dutkowski P; Sinz S; Kessler U; Hess GF; Billeter AT; Müller-Stich BP; Kollmar O; Müller PC
Pharmacology; 2024; 109(2):86-97. PubMed ID: 38368862
[TBL] [Abstract][Full Text] [Related]
10. Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion.
Zervoudakis A; Boucher T; Kemeny NE
Visc Med; 2017 Mar; 33(1):47-53. PubMed ID: 28612017
[TBL] [Abstract][Full Text] [Related]
11. Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival.
Ecker BL; Shin P; Saadat LV; Court CM; Balachandran VP; Chandwani R; Drebin JA; Jarnagin WR; Kingham TP; Soares KC; Vakiani E; Wei AC; Kemeny NE; Smith JJ; Gonen M; D'Angelica MI
Ann Surg; 2022 Feb; 275(2):371-381. PubMed ID: 34793355
[TBL] [Abstract][Full Text] [Related]
12. Case-Based Clinical Guidance on Dosing and Management of the Hepatic Artery Infusion Chemotherapy Pump.
Rao D; Ellis CS; Kemeny N; Cercek A
JCO Oncol Pract; 2024 Feb; 20(2):187-194. PubMed ID: 37883732
[TBL] [Abstract][Full Text] [Related]
13. Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump for Intrahepatic Cancers.
McDonald HG; Zaki OA; Wright MJ; Jayswal R; Weiss H; Nair RT; Ganesh H; Ellis S; Kolesar JM; Moss J; Barry-Hundeyin M; Pandalai PK; Kim J; Patel RA; Cavnar MJ
Ann Surg Oncol; 2024 Feb; 31(2):1252-1263. PubMed ID: 38006531
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases.
Li Y
Gastroenterol Res Pract; 2022; 2022():3546455. PubMed ID: 35529034
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
Aquina CT; Brown ZJ; Beane JD; Ejaz A; Cloyd JM; Tsung A; Adam MO; Pawlik TM; Kim AC
Ann Surg Oncol; 2023 Jan; 30(1):335-344. PubMed ID: 36149611
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma, a Comprehensive Review.
Massani M; Bonariol L; Stecca T
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34207700
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases.
Research And Practice G
Gastroenterol Res Pract; 2023; 2023():9842084. PubMed ID: 37621741
[TBL] [Abstract][Full Text] [Related]
19. Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy.
Ishii N; Nishikawa H; Iwata Y; Enomoto H; Tanaka H; Katakami N; Nishimura T; Iijima H; Nishiguchi S
J Cancer; 2020; 11(5):1223-1230. PubMed ID: 31956368
[No Abstract] [Full Text] [Related]
20. Effective Timing of Surgical Resection of Colorectal Cancer Liver Metastases During Chemotherapy.
Osada S; Gotoh A; Yokoi R; Tsuchiya H; Sakuratani T; Sasaki Y; Okumura N; Hayashi H; Mukai T
Anticancer Res; 2018 Feb; 38(2):737-743. PubMed ID: 29374697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
